对于不受控制的高血压进行脏缩的随机试验:更新的元分析
Syed Hamza Mufarrih1, Nada Qaisar Qureshi1, Mohammed Saud Khan1
1Division of Cardiovascular Medicine, Department of Internal Medicine University of Kentucky Bowling Green KY.
Journal of the American Heart Association
|August 14, 2024
概括
脏缺血 (RDN) 能够有效降低患有失控高血压的患者的血压,而不管他们是否服用药物. 这种微创手术表现出良好的安全性,为治疗耐性高血压提供了新的选择.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 高血压管理 高血压管理
背景情况:
- 许多患者的血压不受控制,尽管他们接受了最佳的医疗治疗.
- 导管式脏缩 (RDN) 是一种新兴的治疗抗性高血压的干预措施.
- 在服用抗高血压药物或不服用抗高血压药物的患者中,RDN的差异性疗效需要进一步阐明.
研究的目的:
- 进行最新的元分析,评估RDN在患有无控制高血压的患者中的疗效和安全性.
- 具体评估RDN对服用抗高血压药物的患者与不服用药物的患者血压的影响.
- 分析RDN疗效在不同试验设计和设备批准中的一致性.
主要方法:
- 在线数据库的系统搜索确定了相关的随机临床试验.
- 包括的试验将RDN与非控制高血压患者的假手术进行了比较.
- 小组分析的重点是假控制试验和使用美国食品和药物管理局批准的RDN设备的试验.
主要成果:
- 分析了15项涉及2581名患者的试验.
- 在服用或未服用抗高血压药物的患者中,RDN显著降低了缩血压.
- 在服用抗高血压药物的患者中,还观察到透气血压的显著降低.
结论:
- RDN是一种有效的治疗方法,用于降低患有失控高血压的患者的血压.
- 该程序在服用或停用抗高血压药物的患者中是安全有效的.
- 在使用FDA批准的设备的模拟控制和当代试验中,RDN的疗效是一致的.
更多相关视频
08:21A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
4.7K
11:08Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.
Published on: February 14, 2018
10.1K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
01:25Antihypertensive Drugs: Direct Renin Inhibitors
513
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
513
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
541
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
541
01:18Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
642
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
642
01:22Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352